{"name":"Pharmosa Biopharm Inc.","slug":"pharmosa-biopharm-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNelRlX1ZBZE1uajZBcjIzY3lySmktancxUGFCWlZJMFFkc1VuS1dXUmRwZlZVRGg0UlJGMm54WXAyOVVWR1RUM0oyOW9RNXEzbW9VUF9GLTJ4SXp0aTZFX29yYkUyZEF5V1JPZkR4YmJTdUFjYXpUVkJvM3JKWi1weElmQkE0YjE1LUJ4MURkNk9rY0ViUVd6ZkZGOWYxUQ?oc=5","date":"2026-04-01","type":"pipeline","source":"openPR.com","summary":"Leading Companies Reinforcing Their Presence in the Liposomal Drug Delivery Devices Market - openPR.com","headline":"Leading Companies Reinforcing Their Presence in the Liposomal Drug Delivery Devices Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE9YN1dBY0lBM2hteEI1Wl9Xc3ZpemNMNEJpMnRJMFpSZ25kVDhQTWN1aEFxSXQxU2EtN3NkN01wbUJCckhDSEF1R2R6OUxtYzUzUEZxWUZyV1N1NU9tU3J6eGRBMA?oc=5","date":"2026-04-01","type":"pipeline","source":"GuruFocus","summary":"Asia Stocks: Research Stocks from Asia Stock Market - GuruFocus","headline":"Asia Stocks: Research Stocks from Asia Stock Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOR0tJWmRXQnZxWk1jcThzQ3JZU2h4T2VMenRjdFZjY0JnUVBYbkE1bHVpRVFlbFlqWmdfcUI3bElVblM1OGQ1R1lEZmpvWTRqZlAxbllhM1ZkT0pGLWJRN0NpdEFEbVNILVlwYW5kV00yaWRHWWlsQmxoLWtvdnZFSnMzeVJlRkxPY08yLWNYWng5enhNaFlURmxOdFJEZw?oc=5","date":"2025-08-14","type":"pipeline","source":"Yahoo Finance","summary":"Pulmonary Hypertension associated with Interstitial Lung Disease Market to Witness Upsurge in Growth During the Forecast Period (2025–2034) | DelveInsight - Yahoo Finance","headline":"Pulmonary Hypertension associated with Interstitial Lung Disease Market to Witness Upsurge in Growth During the Forecast","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-31","type":"regulatory","source":"PR Newswire","summary":"Treatment Resistant Hypertension Market Set to Transform at a CAGR of 5% with Increasing Diagnosis and Treatment of Resistant Patients along with Approval and Development of Newer Therapies During the","headline":"Treatment Resistant Hypertension Market Set to Transform at a CAGR of 5% with Increasing Diagnosis and Treatment of Resi","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxQeHhISHVyb2Z5d2h0aGoyZW4takJhLTlQaDlYbFFlaTRvMnBrN3h6cEttemhWelM0SzRkRFlzVlkzTkdET1dqb2xZcVdjZ0pKWGZIVnd0QnBDRHJjN0J3WXZmaWRpU0g4VndCYk9zSE94dF80VWNWX01MYXpJci02SFozdHlOdlR2TkM0ckNpdjBzVHE5U2hVUzc0U0dMODBXZkNYY08xOFh1OE53eWRRYi03cUIwQlh3d0JvTU41djhNMm9Mc3hBelZldmRETjlQd3ptNmlkY2RuQm9zR1F4WlMzeVQyUnhxeDdBSUNSbjRJX1NLVjI0ZEs0bmY3dWh4dDd1TFZKbjlpNTlIeXdqdm9PWG1mS3hEMTNTTmRjZw?oc=5","date":"2025-01-20","type":"trial","source":"GlobeNewswire","summary":"Advancements in Ocular Hypertension Clinical Trial Pipeline - GlobeNewswire","headline":"Advancements in Ocular Hypertension Clinical Trial Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxOYUZJeXJ2dHd2M0FRR3RrUENEa1h5LWxmSFBEU3R5TVcwRDRYNjJ0NHJrSDBxYlZXUE1jYUtRbzFTMnRBRlNYWm1HbkUyOENjaXloZVB5RzRSSDMwVGcxb1dkT0hHVEZ2OG54ZF9UYk1OZWdwZ0xBU044QVpnVlBBWTdDTnFUYzhPT0gwQkZTUW9kWTRNMnBuTHBlVE1hSjh5VTRFTDlFWDlSQkI5bW5ja3ZWQkJjRVVqYmVpRjYwcXQ4eVhnQ0hYUHYwaV9waG1fUHZPaTN1dkt4NWs?oc=5","date":"2024-10-04","type":"deal","source":"BioSpectrum Asia","summary":"Taiwan's Pharmosa Biopharm expands collaboration with Liquida for smart-technology nebulizers - BioSpectrum Asia","headline":"Taiwan's Pharmosa Biopharm expands collaboration with Liquida for smart-technology nebulizers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQaUxnYldRcUZwNFRwSFhELXFRZXNFbXQ5NElWVWdwdXJvdlc3Nm9TUmFmMWViZjRFX09QWEl1VXRVeFBKaVRudW4wWU9NcmJMbHNPX19PSnNwUk1DajctUWpvR19zWGg2Zm1DTVZaNVlwZnJXWHZEWHJWWVprdXVVOU5sZS05SEtxM1VfMEJiUHNzeEU5TXU0blY2QWxHNXFoN2tFSmZfVHlQc3RNOW90QW52dnF1ZDdwN2NIYUFnNG1obVpP?oc=5","date":"2024-07-29","type":"pipeline","source":"BioPharma APAC","summary":"Taiwan's Global Confluence of Biotech Innovation and Investment: BioAsia Taiwan 2024 - BioPharma APAC","headline":"Taiwan's Global Confluence of Biotech Innovation and Investment: BioAsia Taiwan 2024","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-07-19","type":"pipeline","source":"PR Newswire","summary":"Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Bayer, Merck, Insmed, Acceleron, AbbVie, Alnylam, Apnimed, AstraZeneca, Gossamer B","headline":"Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Ba","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOT1lSbkF5b254OE5US3BQd19BMmRPMWVfWlhwQjVEejFCeE1PaFVNMFAyOWY4STl5VkpMTmNSMmhTbk9iSzR6UGRhRXBlTUxhUVB0ZURDdmFDbFQ4QmxLNlFxUHNsTDExLXZCMndGRGktT0xEdFVwM3Axa1FWMWtwYUF1OGtxYWtuMk4wY1N3bjFad0lCTmdVbUkxbURCRTdkcWx2TUtrU2E4VllBMDlEOQ?oc=5","date":"2023-03-17","type":"pipeline","source":"drugdiscoverytrends.com","summary":"Top 10 promising antihypertensive investigational drugs - drugdiscoverytrends.com","headline":"Top 10 promising antihypertensive investigational drugs","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}